Author:
Bhardwaj Vijay Kumar,Singh Rahul,Sharma Jatin,Das Pralay,Purohit Rituraj
Funder
Board of Research in Nuclear Sciences
Department of Atomic Energy, Mumbai, India
CSIR
Department of Science and Technology, New Delhi, India
Subject
Health Informatics,Computer Science Applications,Software
Reference48 articles.
1. Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors;Anderson;Bioorganic Med. Chem. Lett.,2013
2. 2009, Down syndrome—recent progress and future prospects;Wiseman;Academic.Oup.Com.,2009
3. Structures of down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition;Soundararajan;Structure,2013
4. A. Czarna, J. Wang, D. Zelencova, Y. Liu, X. Deng, Novel Sca ff olds for Dual Speci fi city Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors, (2018).
5. Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity;Kumar;Eur. J. Med. Chem.,2018
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献